[PHARMA] QoQ Quarter Result on 30-Jun-2022 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Aug-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Jun-2022 [#2]
Profit Trend
QoQ- -97.4%
YoY- -94.73%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 880,454 862,720 924,681 761,102 962,174 711,718 2,132,675 -44.58%
PBT 9,193 -638,395 15,589 4,521 37,439 125,088 98,219 -79.41%
Tax -6,427 -5,802 -6,212 -3,607 -8,583 -39,923 -47,895 -73.82%
NP 2,766 -644,197 9,377 914 28,856 85,165 50,324 -85.56%
-
NP to SH 2,648 -644,390 8,617 722 27,734 85,475 49,835 -85.89%
-
Tax Rate 69.91% - 39.85% 79.78% 22.93% 31.92% 48.76% -
Total Cost 877,688 1,506,917 915,304 760,188 933,318 626,553 2,082,351 -43.81%
-
Net Worth -142,812 -248,894 411,327 406,087 413,947 450,411 391,428 -
Dividend
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Div - - 7,859 6,549 10,479 65,466 26,182 -
Div Payout % - - 91.21% 907.17% 37.79% 76.59% 52.54% -
Equity
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Net Worth -142,812 -248,894 411,327 406,087 413,947 450,411 391,428 -
NOSH 1,310,208 1,309,126 1,309,126 1,309,126 1,309,126 1,309,336 1,309,126 0.05%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 0.31% -74.67% 1.01% 0.12% 3.00% 11.97% 2.36% -
ROE 0.00% 0.00% 2.09% 0.18% 6.70% 18.98% 12.73% -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
RPS 67.20 65.86 70.59 58.10 73.45 54.36 162.91 -44.61%
EPS 0.20 -49.19 0.66 0.06 2.12 6.53 3.81 -86.00%
DPS 0.00 0.00 0.60 0.50 0.80 5.00 2.00 -
NAPS -0.109 -0.19 0.314 0.31 0.316 0.344 0.299 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
RPS 61.09 59.86 64.16 52.81 66.76 49.38 147.98 -44.58%
EPS 0.18 -44.71 0.60 0.05 1.92 5.93 3.46 -86.08%
DPS 0.00 0.00 0.55 0.45 0.73 4.54 1.82 -
NAPS -0.0991 -0.1727 0.2854 0.2818 0.2872 0.3125 0.2716 -
Price Multiplier on Financial Quarter End Date
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Date 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 -
Price 0.285 0.545 0.515 0.595 0.755 0.74 0.835 -
P/RPS 0.42 0.83 0.73 1.02 1.03 1.36 0.51 -12.15%
P/EPS 141.02 -1.11 78.29 1,079.54 35.66 11.34 21.93 246.19%
EY 0.71 -90.26 1.28 0.09 2.80 8.82 4.56 -71.09%
DY 0.00 0.00 1.17 0.84 1.06 6.76 2.40 -
P/NAPS 0.00 0.00 1.64 1.92 2.39 2.15 2.79 -
Price Multiplier on Announcement Date
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Date 18/05/23 27/02/23 24/11/22 19/08/22 20/05/22 17/02/22 19/11/21 -
Price 0.38 0.44 0.55 0.595 0.72 0.76 0.845 -
P/RPS 0.57 0.67 0.78 1.02 0.98 1.40 0.52 6.31%
P/EPS 188.02 -0.89 83.61 1,079.54 34.01 11.64 22.20 316.03%
EY 0.53 -111.80 1.20 0.09 2.94 8.59 4.51 -76.03%
DY 0.00 0.00 1.09 0.84 1.11 6.58 2.37 -
P/NAPS 0.00 0.00 1.75 1.92 2.28 2.21 2.83 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment